Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments/Experiment 8/Signature 1
From BugSigDB
Reviewed Marked as Reviewed by Svetlana up on 2024-12-24
Source: Figure 4B
Description: Evaluation of C. difficile abundance by qPCR.
Abundance in Group 1: decreased abundance in FVT-ChP (Chemostat-propagated fecal virome transplantation)
| NCBI | Quality Control | Links |
|---|---|---|
| Clostridioides difficile |
Revision editor(s): Aleru Divine
